Curcumin in exfoliated layered double hydroxide nanoparticles: Pre-clinical evaluation as lung cancer nanomedicine

Colloids Surf B Biointerfaces. 2023 Aug:228:113386. doi: 10.1016/j.colsurfb.2023.113386. Epub 2023 May 30.

Abstract

Rationally designed ∼ 100 nm sized curcumin (CRC) loaded exfoliated layered double hydroxide nanoparticles (X-LDH/CRC-NPs) have been tested for its suitability as nanomedicine in non-small cell lung cancer (NSCLC) cell lines (A549 and NCI-H460) resulting enhanced apoptosis. Preclinical evaluation on A549 tumor bearing nude mouse model confirmed that such a well-designed X-LDH/CRC NPs would be highly advantageous for treating lung cancers.

Keywords: Curcumin; Exfoliated LDH (Layered double hydroxide); In vivo efficacy; Lung cancer therapy.

MeSH terms

  • Animals
  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Cell Line, Tumor
  • Curcumin* / pharmacology
  • Curcumin* / therapeutic use
  • Hydroxides
  • Lung Neoplasms* / pathology
  • Mice
  • Nanomedicine / methods
  • Nanoparticles*

Substances

  • Curcumin
  • Hydroxides